Extending Dosing Intervals Reduces Drug Side Effect Risk
A new study led by NYU Langone multiple sclerosis specialists points to a new way to make an existing drug safer for people with the condition.
Extending Natalizumab Safe for MS Patients
A multiple sclerosis medication linked to a serious side effect has been shown safe in an extended dosing trial by NYU Langone researchers.
Extra Weight in Offspring Linked to C-Section Delivery
NYU Langone study finds mice born by C-section have different gut bacteria than those born vaginally and gain more weight.
Extraordinary Teamwork in OR Saves Patient with Lung Cancer
Dr. Harvey Pass, chief of thoracic surgery at NYU Langone, leads a heroic effort to save a patient who goes into cardiac arrest in the OR.
Face & Double Hand Transplant at NYU Langone Is Successful
A surgical team at NYU Langone performed a face and double hand transplant, the first successful case of its kind in the world.
Face & Double Hand Transplant Delivers a ‘Second Chance’
A car accident left Joe severely impaired, but a 23-hour face and double hand transplant at NYU Langone gave him a second chance.
Face Transplant Helps with Young Californian’s Recovery
Cameron worked hard to recover after a terrible injury; a 25-hour face transplant procedure at NYU Langone greatly improved his quality of life.
Face Transplant Means Man Can Go Back to More-Normal Days
A fire left Patrick severely injured, but a face transplant at NYU Langone, the most extensive such procedure to date, brought a much better life.
FACES Gala Raises Funds for Epilepsy Research
NYU Langone’s 2015 FACES gala raised more than $4.7 million to support epilepsy research, education, and care.
Facial Paralysis & Reanimation Center Helps Restore Smiles
Since 2014 NYU Langone’s Facial Paralysis and Reanimation Center has been marshaling the expertise of clinical specialists from many disciplines.